ID

26907

Description

Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27; ODM derived from: https://clinicaltrials.gov/show/NCT00968214

Lien

https://clinicaltrials.gov/show/NCT00968214

Mots-clés

Versions (1)
  1. 28/10/2017 28/10/2017 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

28 octobre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT00968214

Anglais

Eligibility Breast Cancer NCT00968214

1 Formulaires  
Criteria
Description

Criteria

histologically or cytologically confirmed invasive breast cancer
Description

Invasive carcinoma of breast

Type de données

boolean

Alias
UMLS CUI [1]
C0853879
complete resection of primary tumor
Description

Complete excision Primary tumor

Type de données

boolean

Alias
UMLS CUI [1,1]
C0015250
UMLS CUI [1,2]
C0677930
stage i-iii (t1-3, n0-3, m0) disease
Description

Disease TNM Breast tumor staging

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0474926
enrolled in clinical trial can-ncic-ma27.
Description

Study Subject Participation Status | Clinical Trial Specified

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0008976
UMLS CUI [2,2]
C0205369
no locally recurrent or metastatic breast cancer
Description

Exclusion Criteria | Breast cancer recurrent Local | Secondary malignant neoplasm of female breast

Type de données

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0278493
UMLS CUI [2,2]
C0205276
UMLS CUI [3]
C0346993
hormone receptor status:
Description

Hormone Receptor Status

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
estrogen receptor- or progesterone receptor-positive disease
Description

Disease Estrogen receptor positive | Disease Progesterone receptor positive

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0279754
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0279759
patient characteristics:
Description

Client Characteristics

Type de données

boolean

Alias
UMLS CUI [1]
C0815172
postmenopausal status, defined as one of the following:
Description

Postmenopausal state

Type de données

boolean

Alias
UMLS CUI [1]
C0232970
at least 60 years old
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
age 45-59 years with spontaneous cessation of menses for > 12 months prior to chemotherapy or study randomization
Description

Age | Amenorrhea Spontaneous Duration | Chemotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0002453
UMLS CUI [2,2]
C0205359
UMLS CUI [2,3]
C0449238
UMLS CUI [3]
C0392920
age 45-59 years with cessation of menses for < 12 months or secondary to hysterectomy and a follicle-stimulating hormone (fsh) level in the postmenopausal range (or > 34.4 iu/l)
Description

Age | Amenorrhea Duration | Amenorrhea Secondary to Hysterectomy | FSH measurement Postmenopausal state | FSH measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0002453
UMLS CUI [2,2]
C0449238
UMLS CUI [3,1]
C0002453
UMLS CUI [3,2]
C0175668
UMLS CUI [3,3]
C0020699
UMLS CUI [4,1]
C0202022
UMLS CUI [4,2]
C0232970
UMLS CUI [5]
C0202022
age 45-59 years on hormone replacement therapy (hrt) and discontinued hrt at diagnosis of breast cancer and fsh level in the postmenopausal range (or > 34.4 iu/l)
Description

Age | Hormone replacement therapy | Breast Carcinoma Diagnosis | Hormone replacement therapy Discontinued | FSH measurement Postmenopausal state | FSH measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0282402
UMLS CUI [3,1]
C0678222
UMLS CUI [3,2]
C1704338
UMLS CUI [4,1]
C0282402
UMLS CUI [4,2]
C1444662
UMLS CUI [5,1]
C0202022
UMLS CUI [5,2]
C0232970
UMLS CUI [6]
C0202022
bilateral oophorectomy
Description

Bilateral oophorectomy

Type de données

boolean

Alias
UMLS CUI [1]
C0278321
prior concurrent therapy:
Description

Therapeutic procedure

Type de données

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Description

ID.16

Type de données

boolean

Retour au début de la page

Similar models

Eligibility Breast Cancer NCT00968214

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Invasive carcinoma of breast
Item
histologically or cytologically confirmed invasive breast cancer
boolean
C0853879 (UMLS CUI [1])
Complete excision Primary tumor
Item
complete resection of primary tumor
boolean
C0015250 (UMLS CUI [1,1])
C0677930 (UMLS CUI [1,2])
Disease TNM Breast tumor staging
Item
stage i-iii (t1-3, n0-3, m0) disease
boolean
C0012634 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
Study Subject Participation Status | Clinical Trial Specified
Item
enrolled in clinical trial can-ncic-ma27.
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2,1])
C0205369 (UMLS CUI [2,2])
Exclusion Criteria | Breast cancer recurrent Local | Secondary malignant neoplasm of female breast
Item
no locally recurrent or metastatic breast cancer
boolean
C0680251 (UMLS CUI [1])
C0278493 (UMLS CUI [2,1])
C0205276 (UMLS CUI [2,2])
C0346993 (UMLS CUI [3])
Hormone Receptor Status
Item
hormone receptor status:
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
Disease Estrogen receptor positive | Disease Progesterone receptor positive
Item
estrogen receptor- or progesterone receptor-positive disease
boolean
C0012634 (UMLS CUI [1,1])
C0279754 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0279759 (UMLS CUI [2,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Postmenopausal state
Item
postmenopausal status, defined as one of the following:
boolean
C0232970 (UMLS CUI [1])
Age
Item
at least 60 years old
boolean
C0001779 (UMLS CUI [1])
Age | Amenorrhea Spontaneous Duration | Chemotherapy
Item
age 45-59 years with spontaneous cessation of menses for > 12 months prior to chemotherapy or study randomization
boolean
C0001779 (UMLS CUI [1])
C0002453 (UMLS CUI [2,1])
C0205359 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
C0392920 (UMLS CUI [3])
Age | Amenorrhea Duration | Amenorrhea Secondary to Hysterectomy | FSH measurement Postmenopausal state | FSH measurement
Item
age 45-59 years with cessation of menses for < 12 months or secondary to hysterectomy and a follicle-stimulating hormone (fsh) level in the postmenopausal range (or > 34.4 iu/l)
boolean
C0001779 (UMLS CUI [1])
C0002453 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0002453 (UMLS CUI [3,1])
C0175668 (UMLS CUI [3,2])
C0020699 (UMLS CUI [3,3])
C0202022 (UMLS CUI [4,1])
C0232970 (UMLS CUI [4,2])
C0202022 (UMLS CUI [5])
Age | Hormone replacement therapy | Breast Carcinoma Diagnosis | Hormone replacement therapy Discontinued | FSH measurement Postmenopausal state | FSH measurement
Item
age 45-59 years on hormone replacement therapy (hrt) and discontinued hrt at diagnosis of breast cancer and fsh level in the postmenopausal range (or > 34.4 iu/l)
boolean
C0001779 (UMLS CUI [1])
C0282402 (UMLS CUI [2])
C0678222 (UMLS CUI [3,1])
C1704338 (UMLS CUI [3,2])
C0282402 (UMLS CUI [4,1])
C1444662 (UMLS CUI [4,2])
C0202022 (UMLS CUI [5,1])
C0232970 (UMLS CUI [5,2])
C0202022 (UMLS CUI [6])
Bilateral oophorectomy
Item
bilateral oophorectomy
boolean
C0278321 (UMLS CUI [1])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.16
Item
see disease characteristics
boolean
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial